Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

Recruiting now

Conditions studied: Helicobacter Pylori, Atrophic Gastritis, Intestinal Metaplasia

In brief

Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.

Key facts

Study ID

NCT05053945

Run by

Chinese University of Hong Kong

People needed

260

Starts

2020-05-15

Expected to finish

2025-12-31

Last updated by the study team

2024-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults >= 18 years of age
• Written informed consent obtained
• Diagnosed with current or past H. pylori infection,
• Histologically proven atrophic gastritis (body and/or antrum of stomach), intestinal metaplasia (complete and incomplete), dysplasia (any grade) and/or gastric cancer (post- treatment)

You may not qualify if…

• Co-morbid illness that prohibit endoscopic surveillance
• Declines for study questionnaire, biobanking of specimens and/or regular review per study protocol

Where it is running

• Prince of Wales Hospital — Hong Kong, Hong Kong (enrolling)
• S.H. Ho Centre for Digestive Health, Prince of Wales Hospital — Hong Kong, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.